| JMJD6 licenses ERα-dependent enhancer and coding gene activation by modulating the recruitment of the CARM1/MED12 co-activator complex W Gao, R Xiao, W Zhang, Y Hu, B Peng, W Li, Y He, H Shen, J Ding, ... Molecular cell 70 (2), 340-357. e8, 2018 | 78 | 2018 |
| Arginine methylation of HSP70 regulates retinoid acid-mediated RARβ2 gene activation W Gao, R Xiao, B Peng, H Xu, H Shen, M Huang, T Shi, J Yi, W Zhang, ... Proceedings of the National Academy of Sciences 112 (26), E3327-E3336, 2015 | 72 | 2015 |
| Estrogen-induced circRNA, circPGR, functions as a ceRNA to promote estrogen receptor-positive breast cancer cell growth by regulating cell cycle-related genes L Wang, J Yi, L Lu, Y Zhang, L Wang, G Hu, Y Liu, J Ding, H Shen, F Zhao, ... Theranostics 11 (4), 1732, 2021 | 48 | 2021 |
| Regulation of transcription factor Yin Yang 1 by SET7/9-mediated lysine methylation W Zhang, X Wu, T Shi, H Xu, J Yi, H Shen, M Huang, X Shu, F Wang, ... Scientific Reports 6 (1), 21718, 2016 | 45 | 2016 |
| JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner J Yi, HF Shen, JS Qiu, MF Huang, WJ Zhang, JC Ding, XY Zhu, Y Zhou, ... Nucleic acids research 45 (6), 3503-3518, 2017 | 44 | 2017 |
| A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis B Peng, W Li, J Ding, Y He, T Ran, B Xie, Z Wang, H Shen, R Xiao, W Gao, ... Theranostics 10 (8), 3451, 2020 | 39 | 2020 |
| Methylation of transcription factor YY2 regulates its transcriptional activity and cell proliferation X Wu, T Shi, Y He, F Wang, R Sang, J Ding, W Zhang, X Shu, H Shen, J Yi, ... Cell discovery 3 (1), 1-22, 2017 | 34 | 2017 |
| The dual function of KDM5C in both gene transcriptional activation and repression promotes breast cancer cell growth and tumorigenesis H Shen, W Zhang, Y Huang, Y He, G Hu, L Wang, B Peng, J Yi, T Li, ... Advanced Science 8 (9), 2004635, 2021 | 29 | 2021 |
| CircPVT1 promotes ER‐positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS J Yi, L Wang, G Hu, Y Zhang, J Du, J Ding, X Ji, H Shen, H Huang, F Ye, ... The EMBO Journal 42 (10), e112408, 2023 | 23 | 2023 |
| Use of a novel integrase-deficient lentivirus for targeted anti-cancer therapy with survivin promoter-driven diphtheria toxin A B Lin, A Gao, R Zhang, H Ma, H Shen, Q Hu, H Zhang, M Zhao, X Lan, ... Medicine 94 (31), e1301, 2015 | 15 | 2015 |
| DDB1 binds histone reader BRWD3 to activate the transcriptional cascade in adipogenesis and promote onset of obesity X Wang, HY Wang, GS Hu, WS Tang, L Weng, Y Zhang, H Guo, SS Yao, ... Cell Reports 35 (12), 2021 | 9 | 2021 |
| SF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulation M Cusan, H Shen, B Zhang, A Liao, L Yang, M Jin, M Fernandez, P Iyer, ... The Journal of clinical investigation 133 (17), 2023 | 8 | 2023 |
| ER-localized JmjC domain-containing protein JMJD8 targets STING to promote immune evasion and tumor growth in breast cancer J Yi, L Wang, J Du, M Wang, H Shen, Z Liu, Y Qin, J Liu, G Hu, R Xiao, ... Developmental Cell 58 (9), 760-778. e6, 2023 | 5 | 2023 |
